{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:04:31Z","timestamp":1793160271457,"version":"4.5.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:00:00Z","timestamp":1642118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T00:00:00Z","timestamp":1642118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Breast Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Patients with a biopsy diagnosis of ductal carcinoma in situ (DCIS) may be diagnosed with invasive breast cancer after excision. We evaluated the preoperative clinical and imaging predictors of DCIS that were associated with an upgrade to invasive carcinoma on final pathology and also compared the diagnostic performance of various statistical models. We reviewed the medical records; including mammography, ultrasound (US), and magnetic resonance imaging (MRI) findings; of 644 patients who were preoperatively diagnosed with DCIS and who underwent surgery between January 2012 and September 2018. Logistic regression and three machine learning methods were applied to predict DCIS underestimation. Among 644 DCIS biopsies, 161 (25%) underestimated invasive breast cancers. In multivariable analysis, suspicious axillary lymph nodes (LNs) on US (odds ratio [OR], 12.16; 95% confidence interval [CI], 4.94\u201329.95;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001) and high nuclear grade (OR, 1.90; 95% CI, 1.24\u20132.91;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.003) were associated with underestimation. Cases with biopsy performed using vacuum-assisted biopsy (VAB) (OR, 0.42; 95% CI, 0.27\u20130.65;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009&lt;\u20090.001) and lesion size &lt;2\u2009cm on mammography (OR, 0.45; 95% CI, 0.22\u20130.90;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.021) and MRI (OR, 0.29; 95% CI, 0.09\u20130.94;\n                    <jats:italic>P<\/jats:italic>\n                    \u2009=\u20090.037) were less likely to be upgraded. No significant differences in performance were observed between logistic regression and machine learning models. Our results suggest that biopsy device, high nuclear grade, presence of suspicious axillary LN on US, and lesion size on mammography or MRI were independent predictors of DCIS underestimation.\n                  <\/jats:p>","DOI":"10.1038\/s41523-021-00364-z","type":"journal-article","created":{"date-parts":[[2022,1,14]],"date-time":"2022-01-14T06:02:40Z","timestamp":1642140160000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Ductal carcinoma in situ: a risk prediction model for the underestimation of invasive breast cancer"],"prefix":"10.1038","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9386-5772","authenticated-orcid":false,"given":"Ko Woon","family":"Park","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seon Woo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heewon","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0624-5215","authenticated-orcid":false,"given":"Minsu","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boo-Kyung","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Young","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Soo","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eun Yoon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9714-7575","authenticated-orcid":false,"given":"Soo Youn","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0399-7956","authenticated-orcid":false,"given":"Eun Sook","family":"Ko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,14]]},"reference":[{"key":"364_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s11864-012-0217-1","volume":"14","author":"N Bijker","year":"2013","unstructured":"Bijker, N., Donker, M., Wesseling, J., den Heeten, G. J. & Rutgers, E. J. Is DCIS breast cancer, and how do I treat it? Curr. Treat. Options Oncol. 14, 75\u201387 (2013).","journal-title":"Curr. Treat. Options Oncol."},{"key":"364_CR2","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.breast.2012.06.009","volume":"21","author":"C Trentin","year":"2012","unstructured":"Trentin, C. et al. Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 cases. Breast 21, 635\u2013640 (2012).","journal-title":"Breast"},{"key":"364_CR3","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s41416-018-0276-6","volume":"119","author":"CJC Meurs","year":"2018","unstructured":"Meurs, C. J. C. et al. A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: based on 2892 biopsies and 589 invasive cancers. Br. J. Cancer 119, 1155\u20131162 (2018).","journal-title":"Br. J. Cancer"},{"key":"364_CR4","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.1245\/s10434-017-5927-y","volume":"24","author":"JW Jakub","year":"2017","unstructured":"Jakub, J. W. et al. A validated nomogram to predict upstaging of ductal carcinoma in situ to invasive disease. Ann. Surgical Oncol. 24, 2915\u20132924 (2017).","journal-title":"Ann. Surgical Oncol."},{"key":"364_CR5","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.breast.2012.06.012","volume":"21","author":"J Kim","year":"2012","unstructured":"Kim, J. et al. Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision. Breast 21, 641\u2013645 (2012).","journal-title":"Breast"},{"key":"364_CR6","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1148\/radiol.11102368","volume":"260","author":"ME Brennan","year":"2011","unstructured":"Brennan, M. E. et al. Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer. Radiology 260, 119\u2013128 (2011).","journal-title":"Radiology"},{"key":"364_CR7","unstructured":"National Guideline Alliance. in Early and Locally Advanced Breast Cancer: Diagnosis and Management National Institute for Health and Care Excellence: Clinical Guidelines (National Institute for Health and Care Excellence (UK, 2018)."},{"key":"364_CR8","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.6004\/jnccn.2018.0083","volume":"16","author":"TB Bevers","year":"2018","unstructured":"Bevers, T. B. et al. Breast cancer screening and diagnosis, version 3.2018, NCCN clinical practice guidelines in oncology. J. Natl Compr. Cancer Netw. 16, 1362\u20131389 (2018).","journal-title":"J. Natl Compr. Cancer Netw."},{"key":"364_CR9","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/jcp.2008.061457","volume":"62","author":"B Doyle","year":"2009","unstructured":"Doyle, B. et al. Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified? J. Clin. Pathol. 62, 534\u2013538 (2009).","journal-title":"J. Clin. Pathol."},{"key":"364_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1007\/s10549-006-9167-2","volume":"98","author":"A Goyal","year":"2006","unstructured":"Goyal, A. et al. Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases. Breast Cancer Res. Treat. 98, 311\u2013314 (2006).","journal-title":"Breast Cancer Res. Treat."},{"key":"364_CR11","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s11548-018-1900-x","volume":"14","author":"J Li","year":"2019","unstructured":"Li, J. et al. Predicting underestimation of ductal carcinoma in situ: a comparison between radiomics and conventional approaches. Int. J. computer Assist. Radiol. Surg. 14, 709\u2013721 (2019).","journal-title":"Int. J. computer Assist. Radiol. Surg."},{"key":"364_CR12","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1002\/cncr.22216","volume":"107","author":"L Huo","year":"2006","unstructured":"Huo, L. et al. Predictors of invasion in patients with core-needle biopsy-diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ. Cancer 107, 1760\u20131768 (2006).","journal-title":"Cancer"},{"key":"364_CR13","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1111\/cas.12381","volume":"105","author":"T Osako","year":"2014","unstructured":"Osako, T. et al. Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ. Cancer Sci. 105, 576\u2013582 (2014).","journal-title":"Cancer Sci."},{"key":"364_CR14","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/jso.23273","volume":"107","author":"HS Park","year":"2013","unstructured":"Park, H. S. et al. Risk predictors of underestimation and the need for sentinel node biopsy in patients diagnosed with ductal carcinoma in situ by preoperative needle biopsy. J. Surgical Oncol. 107, 388\u2013392 (2013).","journal-title":"J. Surgical Oncol."},{"key":"364_CR15","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s12282-015-0636-5","volume":"23","author":"Y Sato","year":"2016","unstructured":"Sato, Y. et al. Preoperatively diagnosed ductal carcinoma in situ: risk prediction of invasion and effects on axillary management. Breast Cancer 23, 761\u2013770 (2016).","journal-title":"Breast Cancer"},{"key":"364_CR16","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.ejrad.2014.01.010","volume":"83","author":"AY Park","year":"2014","unstructured":"Park, A. Y. et al. Ductal carcinoma in situ diagnosed at US-guided 14-gauge core-needle biopsy for breast mass: preoperative predictors of invasive breast cancer. Eur. J. Radiol. 83, 654\u2013659 (2014).","journal-title":"Eur. J. Radiol."},{"key":"364_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.25259\/JCIS_48_2021","volume":"11","author":"A Bragg","year":"2021","unstructured":"Bragg, A. et al. Imaging of non-calcified ductal carcinoma in situ. J. Clin. Imaging Sci. 11, 1\u20136 (2021).","journal-title":"J. Clin. Imaging Sci."},{"key":"364_CR18","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1126\/science.293.5537.2051","volume":"293","author":"E Mjolsness","year":"2001","unstructured":"Mjolsness, E. & DeCoste, D. Machine learning for science: state of the art and future prospects. Science 293, 2051\u20132055 (2001).","journal-title":"Science"},{"key":"364_CR19","doi-asserted-by":"publisher","first-page":"5162","DOI":"10.1002\/mp.12453","volume":"44","author":"N Antropova","year":"2017","unstructured":"Antropova, N., Huynh, B. Q. & Giger, M. L. A deep feature fusion methodology for breast cancer diagnosis demonstrated on three imaging modality datasets. Med. Phys. 44, 5162\u20135171 (2017).","journal-title":"Med. Phys."},{"key":"364_CR20","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s10549-017-4572-2","volume":"167","author":"V Sopik","year":"2018","unstructured":"Sopik, V. et al. Impact of microinvasion on breast cancer mortality in women with ductal carcinoma in situ. Breast Cancer Res. Treat. 167, 787\u2013795 (2018).","journal-title":"Breast Cancer Res. Treat."},{"key":"364_CR21","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1002\/bjs.9337","volume":"100","author":"SK Lee","year":"2013","unstructured":"Lee, S. K., Yang, J. H., Woo, S. Y., Lee, J. E. & Nam, S. J. Nomogram for predicting invasion in patients with a preoperative diagnosis of ductal carcinoma in situ of the breast. Br. J. Surg. 100, 1756\u20131763 (2013).","journal-title":"Br. J. Surg."},{"key":"364_CR22","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1177\/0284185113484640","volume":"54","author":"SY Hahn","year":"2013","unstructured":"Hahn, S. Y. et al. MR features to suggest microinvasive ductal carcinoma of the breast: can it be differentiated from pure DCIS? Acta Radiol. 54, 742\u2013748 (2013).","journal-title":"Acta Radiol."},{"key":"364_CR23","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.jamcollsurg.2004.11.012","volume":"200","author":"TW Yen","year":"2005","unstructured":"Yen, T. W. et al. Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ. J. Am. Coll. Surg. 200, 516\u2013526 (2005).","journal-title":"J. Am. Coll. Surg."},{"key":"364_CR24","unstructured":"Sickles, E. A. et al. ACR BI-RADS\u00ae Atlas, Breast Imaging Reporting and Data System. 5th edn (American College of Radiology, 2013)."},{"key":"364_CR25","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/jso.24037","volume":"112","author":"T Kondo","year":"2015","unstructured":"Kondo, T. et al. A model to predict upstaging to invasive carcinoma in patients preoperatively diagnosed with ductal carcinoma in situ of the breast. J. Surgical Oncol. 112, 476\u2013480 (2015).","journal-title":"J. Surgical Oncol."},{"key":"364_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s12282-012-0364-z","volume":"19","author":"T Uematsu","year":"2012","unstructured":"Uematsu, T. Non-mass-like lesions on breast ultrasonography: a systematic review. Breast Cancer 19, 295\u2013301 (2012).","journal-title":"Breast Cancer"},{"key":"364_CR27","doi-asserted-by":"publisher","first-page":"3542","DOI":"10.1007\/s00330-015-4201-6","volume":"26","author":"JS Choi","year":"2016","unstructured":"Choi, J. S. et al. Additional diagnostic value of shear-wave elastography and color Doppler US for evaluation of breast non-mass lesions detected at B-mode US. Eur. Radiol. 26, 3542\u20133549 (2016).","journal-title":"Eur. Radiol."},{"key":"364_CR28","unstructured":"World Health Organisation. WHO Classification of Tumours: Breast Tumours 5th edn, Vol. 2 (International Agency for Research on Cancer, 2019)"},{"key":"364_CR29","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1109\/TAC.1974.1100705","volume":"19","author":"H Akaike","year":"1974","unstructured":"Akaike, H. A new look at the statistical model identification. IEEE Trans. Autom. Control 19, 716\u2013723 (1974).","journal-title":"IEEE Trans. Autom. Control"},{"key":"364_CR30","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/sim.1997","volume":"24","author":"N Nagelkerke","year":"2005","unstructured":"Nagelkerke, N., Smits, J., le Cessie, S. & van Houwelingen, H. Testing goodness-of-fit of the logistic regression model in case-control studies using sample reweighting. Stat. Med. 24, 121\u2013130 (2005).","journal-title":"Stat. Med."}],"container-title":["npj Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41523-021-00364-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-021-00364-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41523-021-00364-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,24]],"date-time":"2022-11-24T09:20:11Z","timestamp":1669281611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41523-021-00364-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,14]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["364"],"URL":"https:\/\/doi.org\/10.1038\/s41523-021-00364-z","relation":{},"ISSN":["2374-4677"],"issn-type":[{"value":"2374-4677","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,14]]},"assertion":[{"value":"27 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}